Condition deep-dive · 7 min read

Endometriosis supplement protocol — what the evidence actually shows

Updated 2026-05-11 · Reviewed by SupplementScore editors · No sponsorships

Endometriosis is a chronic estrogen-dependent inflammatory disease in which endometrial-like tissue grows outside the uterus, causing dysmenorrhoea, dyspareunia, pelvic pain, and infertility. It affects roughly 1 in 10 women of reproductive age, with an average diagnostic delay of 7–10 years that is itself a major source of harm. The supplement layer is small but real: omega-3, NAC, curcumin, and vitamin D have trial signals on pain and inflammatory markers. None of these substitute for medical or surgical management — hormonal suppression (combined contraceptive pills, progestins, GnRH agonists/antagonists) and laparoscopic excision by an endometriosis specialist remain the evidence-based core treatments.

Read this first. Persistent or progressive pelvic pain, severe dysmenorrhoea, deep dyspareunia, infertility, or cyclical bowel/bladder symptoms warrant evaluation — endometriosis is commonly missed. Refer to a gynaecologist with endometriosis-specific expertise; excision surgery by a specialist is meaningfully different in outcomes from generalist ablation. Supplements do not treat endometriosis tissue; they may help with inflammation and pain as adjuncts.

What actually has trial evidence as an adjunct

Tier 2 evidence · Best-studied supplement

Omega-3 EPA/DHA

1.5–2 g EPA+DHA combined/day with a fatty meal

Omega-3 fatty acids modulate prostaglandin balance toward less inflammatory series-3 prostaglandins. Several trials in dysmenorrhoea (including endometriosis-associated pain) show reductions in pain scores and NSAID consumption. Effect size is modest but consistent. Combine with anti-inflammatory dietary pattern.

Tier 2 evidence · Cyst-related

N-Acetyl Cysteine (NAC)

600 mg three times daily; 3-month trial

The Porpora 2013 Italian trial reported that NAC 600 mg t.i.d. for 3 months produced reduction in endometrioma size in some users and improvements in pain scores. The trial was small and unblinded; subsequent replication is limited. Reasonable as an adjunct given low risk and modest cost; not a substitute for surgery in symptomatic endometriomas.

Tier 3 evidence · Anti-inflammatory adjunct

Curcumin (bioavailable form)

500 mg b.i.d. of a bioavailable curcumin (phytosome, BCM-95, or similar)

Mechanistic plausibility (NF-κB inhibition, prostaglandin modulation, anti-angiogenic effects); small clinical trials specifically in endometriosis are limited but suggestive. Reasonable adjunct as part of an inflammation-focused approach. Caution with anticoagulants.

Tier 2 evidence · In confirmed deficiency

Vitamin D3 (to target)

2,000–4,000 IU/day to a 25-OH-D target of 30–50 ng/mL

Vitamin D deficiency is over-represented in endometriosis cohorts; small trials show modest pain reduction with repletion in deficient users. Test 25-OH-D first.

Tier 3 evidence · Iron management

Iron (ferrous bisglycinate) for menstrual blood loss-related anemia

Ferrous bisglycinate 30 mg elemental every other day, if ferritin < 30–50 ng/mL

Heavy menstrual bleeding and chronic blood loss are common; iron-deficiency anemia is frequently undertreated. Test ferritin and hemoglobin; replete if deficient.

Tier 3 evidence · Adjunct for pain

Palmitoylethanolamide (PEA)

300–600 mg/day; 3-month trial

PEA is an endogenous fatty acid amide with anti-inflammatory and analgesic properties (PPAR-α agonist). Small trials in pelvic pain and endometriosis (Indraccolo 2010 and others) suggest modest pain reduction. Reasonable in users with persistent pain despite first-line medical therapy; expensive, so a clear stopping rule is sensible.

What dominates over supplements — the actual treatment

Hormonal suppression — combined oral contraceptive pills (continuous or extended cycle), progestin-only options (norethindrone, dienogest), levonorgestrel IUDs, GnRH antagonists (elagolix, relugolix combination therapy), and depot leuprolide reduce pain and disease activity. First-line for most users with confirmed or suspected endometriosis-associated pain.
Specialist excision surgery — laparoscopic excision by an endometriosis specialist outperforms ablation and provides histologic diagnosis. Outcomes are surgeon-dependent.
NSAIDs as first-line pain management — alongside hormonal suppression. Mefenamic acid, naproxen, and others.
Pelvic floor physiotherapy — endometriosis-associated chronic pelvic pain commonly drives pelvic floor dysfunction; specialised PT reduces pain and dyspareunia.
Multidisciplinary pain management — chronic pelvic pain often requires pain specialist input, neuromodulation (gabapentin, amitriptyline), and CBT.
Anti-inflammatory dietary pattern — Mediterranean-style; observational evidence suggests modest pain benefit; ultra-processed food reduction is reasonable.
Fertility care — IVF is often the most effective fertility treatment in endometriosis; coordinated reproductive endocrinology and endometriosis-specialist care.

What to skip

"Estrogen detox" supplements (DIM, calcium-D-glucarate, indole-3-carbinol high-dose) — endometriosis is estrogen-dependent but the supplement-route "detox" is not a recognised endometriosis treatment; medical hormonal suppression is. DIM can affect cytochrome P450 metabolism of medications.
Generic "women's hormone balance" blends with vitex, dong quai, and various honourable mentions — vitex in particular has unclear effects in endometriosis and may be counterproductive.
Wild yam creams as "natural progesterone" — wild yam diosgenin is NOT converted to progesterone in the human body.
Castor oil packs as primary treatment — popular in alternative medicine for endometriosis; no RCT evidence.
Mega-dose iodine for "estrogen detoxification" — wildly inappropriate; iodine excess causes thyroid dysfunction.
Cannabis / CBD as a primary endometriosis treatment — modest signals on pelvic pain in observational data; not a substitute for medical management.
Soy isoflavones in significant amounts — endometriosis-specific evidence is mixed; some concern about phytoestrogen effect in an estrogen-dependent disease. Modest dietary soy is fine; high-dose isoflavone supplements should be discussed with the gynaecologist.

What to track

Pain (VAS or NRS scale, dysmenorrhoea severity, dyspareunia, non-cyclical pelvic pain) is the standard endpoint. Health-related quality of life measures (EHP-30 is endometriosis-specific) capture impact. Cyclical patterns matter — many users find tracking symptoms across their cycle clarifies what's working. Reassess at 12 weeks of any supplement intervention; supplements are adjuncts, so the primary trend should be evaluated alongside medical/surgical management.

Practical quick-start. Establish or confirm diagnosis with a gynaecologist with endometriosis-specific expertise. First-line treatment is medical hormonal suppression with NSAIDs as needed; specialist excision when symptoms persist or fertility is the goal. Pelvic floor physiotherapy for chronic pelvic pain. For the supplement layer as adjunct: omega-3 EPA+DHA 1.5–2 g/day + vitamin D3 to target if deficient + bioavailable curcumin 500 mg b.i.d. + consider NAC 600 mg t.i.d. for 3 months. Track ferritin and replete if low. Reassess at 12 weeks.